Page last updated: 2024-10-30

lomerizine and Papilledema

lomerizine has been researched along with Papilledema in 1 studies

lomerizine: used to treat migraines

Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savigni, DL1
O'Hare Doig, RL1
Szymanski, CR1
Bartlett, CA1
Lozić, I1
Smith, NM1
Fitzgerald, M1

Other Studies

1 other study available for lomerizine and Papilledema

ArticleYear
Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
    Neuropharmacology, 2013, Volume: 75

    Topics: Adenosine Triphosphate; Animals; Basic Helix-Loop-Helix Transcription Factors; Calcium Channel Block

2013